Zobrazeno 1 - 10
of 113
pro vyhledávání: '"G. Rangoni"'
Autor:
Gerardo Rosati, Sara Lonardi, Fabio Galli, Maria Di Bartolomeo, Monica Ronzoni, Maria G. Zampino, Maria Banzi, Alberto Zaniboni, Felice Pasini, Silvia Bozzarelli, Silvio K. Garattini, Daris Ferrari, Vincenzo Montesarchio, Andrea Mambrini, Libero Ciuffreda, Francesca Galli, Valeria Pusceddu, Chiara Carlomagno, Paolo Bidoli, Domenico Amoroso, Anna M. Bochicchio, Luca Frassineti, Domenico Corsi, Domenico Bilancia, Alessandro Pastorino, Alfonso De Stefano, Roberto Labianca, D. Bilancia, G. Rosati, V. Montesarchio, R.V. Iaffaioli, G. Nasti, B. Daniele, V. Zagonel, S. Lonardi, N. Pella, G. Aprile, F. Pasini, Roma P. Marchetti, A. Romiti, L. Ciuffreda, D. Ferrari, P. Foa, A. Zaniboni, R. Labianca, S. Mosconi, A. Sobrero, P. Bidoli, M. Cazzaniga, G.D. Beretta, D.C. Corsi, E. Cortesi, S. Barni, F. Petrelli, P. Allione, A.M. D'Arco, G. Valmadre, E. Piazza, E. Veltri, G. Vietti Ramus, L. Giustini, S. Tumulo, S. Cascinu, C. Granetto, F. Testore, M. Giordano, M. Moroni, M. Di Seri, A. Nuzzo, L. Angelelli, S. Gori, G. Farina, M. Aglietta, R. Franchi, M. Comandé, P. Giordani, G. Tonini, E. Bucci, A. Ballestrero, M. Benasso, C. Graiff, S. Bravi, O. Caffo, R.R. Silva, L. Frontini, S. Rota, L. Cozzi, M. Cantore, E. Maiello, S. Cinieri, N. Silvestris, S. Romito, V. Gebbia, M. Banzi, A. Santoro, F. Artioli, R. Mattioli, A. Contu, F. Di Costanzo, F. Leonardi, L. Cavanna, R. Passalacqua, D. Amoroso, P. Sozzi, M. D'Amico, D. Amadori, L. Frassineti, D. Turci, A. Ravaioli, E. Pasquini, A. Gambi, M. Faedi, G. Cruciani, E. Bajetta, M. Di Bartolomeo, L. Gianni, M. Ronzoni, M.T. Ionta, B. Massidda, M. Scartozzi, M.G. Zampino, A.M. Bochicchio, A. Ciarlo, A. Di Leo, S. Frustaci, G. Rangoni, A. Arizzoia, L. Pavesi, C. Verusio, G. Pinotti, A. Iop, S. De Placido, C. Carlomagno, V. Adamo, C. Ficorella, D. Natale, E. Greco, E. Rulli, F. Galli, D. Poli, L. Porcu, V. Torri
Background: Previous studies on oxaliplatin and fluoropyrimidines as adjuvant therapy in older patients with stage III colon cancer (CC) produced conflicting results. Patients and methods: We assessed the impact of age on time to tumour recurrence (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68fe67a06214c156899f253a2fbfbb53
https://hdl.handle.net/10281/401680
https://hdl.handle.net/10281/401680
Autor:
Ausilia Maria Manganoni, Alfredo Berruti, William Vermi, Francesco Guarneri, Marina Venturini, Francesca Consoli, Fausto Petrelli, G. Rangoni, Pier Giacomo Calzavara Pinton, Paolo Incardona, Salvatore Grisanti
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 4, p e0214884 (2019)
PLoS ONE, Vol 14, Iss 4, p e0214884 (2019)
Panniculitis and vitiligo-like lesions have been recently identified as rare cutaneous side effects of the combination of BRAF and MEK inhibitors, a standard of care in metastatic and locally advanced BRAF V600 mutated melanoma. An immune-mediated me
Autor:
Vito Amoroso, G. Rangoni, Vittorio Ferrari, Salvatore Grisanti, Giovanni Marini, Lucia Vassalli, Patrizia Marpicati, Edda Simoncini, Nadia Pasinetti, Francesca Valcamonico
Publikováno v:
Oncology. 69:283-289
Objective: To assess the feasibility and activity of a combination schedule with irinotecan (CPT-11), oxaliplatin (L-OHP), brief infusional fluorouracil (5-FU) and folinic acid (FA) as first-line treatment in metastatic colorectal cancer (MCC) patien
Autor:
Francesca Valcamonico, Giuseppina Arcangeli, Carlo Cappelli, Andrea Delbarba, Maurizio Castellano, Alfredo Berruti, Vittorio Ferrari, G. Rangoni, Alberto Dalla Volta
Publikováno v:
Journal of Clinical Oncology. 34:525-525
525 Background: Sunitinib (S) is a standard first line treatment of metastatic renal cell carcinoma (mRCC). Asthenia and fatigue are the most prevalent toxicities but the relevant causes are not fully elucidated. Since endocrine glands are highly vas
Autor:
Salvatore Grisanti, Lucia Vassalli, Patrizia Marpicati, Vito Amoroso, Vittorio Ferrari, Giovanni Marini, G. Rangoni, Edda Simoncini, Francesca Valcamonico
Publikováno v:
Journal of neuro-oncology. 91(1)
We report the case of a 75-year old woman who received sorafenib (Nexavar®, Bayer Pharmaceuticals Corporation, West Haven, CT) for a CNS relapse of clear cell renal cell carcinoma. After four months of sorafenib treatment, a brain magnetic resonance
Autor:
Ruggero Comi, E De Ponti, Marilena Crippa, M. Dal Canto, HI Nielsen, G Rangoni, M Mignini Renzini, M Mastrolilli, H Cepparo, Fausta Brambillasca, A. Villa, Rubens Fadini
Publikováno v:
Reproductive biomedicine online. 13(2)
In March 2004, a new law was introduced in Italy to regulate assisted reproduction; at present it is impossible to use more than a maximum of three oocytes per IVF cycle, nor can embryos or prezygotes (2PN cells) be selected or cryopreserved. The pro
Autor:
Salvatore Grisanti, Giovanni Marini, Guido A. M. Tiberio, G. Rangoni, Franco Nodari, Edda Simoncini, Lucia Vassalli, Vito Amoroso, Patrizia Marpicati, Carla Strina, Francesca Valcamonico, Vittorio Ferrari
Publikováno v:
Cancer chemotherapy and pharmacology. 57(2)
Introduction: Single agent gemcitabine (GEM) is the standard treatment of pancreatic adenocarcinoma. Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor. Recent studies in human pancreatic tumor cell lines suggest an involvement of COX-2 in t
Autor:
Laura Ardighieri, Lucia Vassalli, Salvatore Grisanti, Giovanni Marini, G. Rangoni, Edda Simoncini, Vito Amoroso, Laura Lucini, Francesca Valcamonico, Vittorio Ferrari, Patrizia Marpicati
Publikováno v:
Oncology. 68(1)
Aim: To describe clinical features, treatment modalities and long-term outcome of patients with overt metastatic breast cancer in complete remission for more than 5 years. Patients and Methods: A retrospective survey of 12 patients who were referred
Autor:
V.D. Ferrari, F. Consoli, S. Grisanti, Francesca Valcamonico, E. Simoncini, Vito Amoroso, D. Sgotti, P. Marpicati, Lucia Vassalli, G. Rangoni
Publikováno v:
European Journal of Cancer Supplements. 7:195-196
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.